Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome

Chinese Journal of Integrative Medicine

Volumn 15, Issue 5, 2009, Pages 337-340

  Wang, Yun Long ^a   An, Dong Qing ^a   Ma, Ning ^a   Zhu, Meng ^a   Sun, Hong Yan ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Coronary heart disease; D dimer; Fibrinogen; Turbidity phlegm booking syndrome; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR; D DIMER; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMPTOMATOLOGY; SYNDROME; THROMBOSIS; TURBIDITY PHLEGM BLOCKING SYNDROME;

CASE-CONTROL STUDIES; CORONARY DISEASE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 70350046255     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-009-0337-z     Document Type: Article

References (9)

1. Wang ZY, Li JZ, Ruan CG, Song JJ, Wang HL, Han ZC eds. Thrombosis and hemostasis: basic principles and clinical practice. 4th ed. Shanghai: Shanghai Scientific and Technical Publishers; 2004:529-531.
2. Chinese Society of Cardiovascular Diseases, Chinese Medical Association. Guidance for diagnosis and treatment of chronic stable angina pectonis. Chin J Cardiol (Chin) 2007;35:195-200.
3. Chinese Society of Cardiovascular Diseases. Guidance for diagnosis and treatment of unstable angina and non-ST elevated myocardial infarction. Chin J Cardiol (Chin) 2007;36:1-6.
4. Zheng XY, ed. Guiding principle of clinical research on new drugs of Chinese medicine. Beijng: China Press of Traditional Chinese Medicine; 2002:68-73.
5. Zhao MF, An DQ. Preliminary investigation on syndromes of dirty phlegm stagnation of chest stuffiness in Xinjiang as well as its prevention and treatment. Xinjiang J Tradit Chin Med (Chin) 2008; 26:84-85.
6. Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferneres J, et al. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. Circulation 2004;109:1343-1348. (Pubitemid 38387818)
7. Wang R, Hu DN. Significance of D-dimer and fibrinogen in patients with different kinds of coronary heart disease.Chin Med Herald (Chin) 2006; 35:157-158.
8. Zheng YS, Zheng QP, Duan LF, Zhang LP. Relationships between plasma D-dimer and coronary heart disease. J Clin Cardiol (Chin) 2004; 20:83-85.
9. An DQ, Zhao MF, Zheng J, Hu JX. Discussion on chest fullness of phlegm-turbidity stagnation syndrome in Xinjiang. Xinjiang J Tradit Chin Med (Chin) 2007; 2:1-2.